Sasso and colleagues leveraged organ-specific miRNAs by engineering synthetic mRNA vaccines containing miR target sites to generate a functional map of immunologically competent organs. This work lays the foundation for novel vaccines designed to target the most immunologically proficient organs. They subsequently applied this approach to de-immunize Cas9, rendering it immunologically masked.